Power Law company profile

Verona Pharma

Biotech & Life Sciences · London, United Kingdom · Founded 2005 · IPO 2017 Decacorn

First-in-class inhaled therapies for chronic respiratory diseases

Valuation

$10B

Market cap · 2026

Revenue

$222M

Latest reported FY

Featured in Decacorn$10B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

9 investors on Verona Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 9 investors entered at this stage

Aisling Capital

Janus Henderson Investors

Vivo Capital

OrbiMed

Andera Partners

Novo Ventures

Abingworth

NEA

Arthurian Life Sciences

Global footprint

Where Verona Pharma has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States96.2%

🇬🇧 United Kingdom2.5%

🇲🇦 Morocco0.5%

🇨🇦 Canada0.5%

🇫🇷 France0.5%

5 countries shown

Web traffic by country

8K monthly visits
across markets

🇺🇸 United States58.8%

🇬🇧 United Kingdom13.8%

🇪🇸 Spain10%

🇮🇳 India10%

🇵🇭 Philippines6.3%

Top 5 markets shown

Patent intelligence

$68M patent portfolio · 34 active families

Estimated portfolio value

$68M

0.68% of market cap · 2.4× smaller than top peer Amicus Therapeutics ($164M)

34 active patent families

Where Verona Pharma innovates PharmacologyPyrimidineIsoquinolinePharmaceutical drugPharmaceutical Substances

Where Verona Pharma concentrates vs peers

Each axis is a top-10 topic across Verona Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Verona Pharma

An AI-synthesized read of the highest-engagement posts about Verona Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Verona Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles